Option Care plans to complete stock repurchase in Q4
By HME News Staff
Updated 8:51 AM CST, Thu December 7, 2023
BANNOCKBURN, Ill. – Option Care Health plans to complete the remaining $75 million of repurchases in the fourth quarter under an original authorization. In addition, the company’s board of directors approved an increase to its share repurchase program authorization from $250 million to $500 million. The program has no specified expiration date. During a call in October to discuss its third quarter earnings, Option Care said it had completed a repurchase of approximately $100 million in stock roughly equal to the $106 million breakup fee of its dissolved deal with Amedysis and had repurchased $175 million in stock year-to-date.
Comments